Bruker Gets Health Canada Approval for IVD MALDI Biotyper, Closes Michrom Acquisition

The approval marks the first acceptance of the IVD MALDI Biotyper system for clinical use outside of Europe. The company is also preparing a submission to the US Food and Drug Administration for clearance of the device.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.